DocMorris posts Q3 2026 adjusted EBITDA of CHF 600,000

DocMorris reached adjusted EBITDA breakeven ahead of schedule in Q3 2026, posting CHF 600,000. September’s full repurchase of its CHF 49.6 million 2028 convertible bond was financed through a new convertible bond maturing in 2031. The 2026 adjusted EBITDA forecast improved to better than minus CHF 10 million, previously minus CHF 10 million to minus CHF 17.5 million. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DocMorris AG published the original content used to generate this news brief via EQS News (Ref. ID: adhoc_2416062_de) on October 15, 2026, and is solely responsible for the information contained therein. (C)